Benitec Biopharma (FRA:BJ93) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BJ93 Benitec Biopharma Inc FRA:BJ93
34 GF Score
Price €3.06
View Full Analysis

What is Benitec Biopharma FFO?

FFO (Funds from operations) only applies to REITs.

FRA:BJ93
34GF Score
Benitec Biopharma Inc FRA:BJ93
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Business Description

Other Exchanges BNTC:USA
Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for FRA:BJ93

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.06
Price